TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/23 07:31 | 12/26/23 | MBRX | Moleculin Biotech, Inc. | Health | Drug | Pharmaceutical Preparations | Klemp Walter V | TX | DO | CEO,P | P | 130 | 0.6900 | 0 | 188 | 38 | 681 | D | |||||||||||||||
11/28/22 18:00 | 11/25/22 | MBRX | Moleculin Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klemp Walter V | TX | DO | CEO,P | P | 58 | 1.28 | 0 | 45 | 12 | 410 | D | ||||||||||||||
11/23/22 08:30 | 11/21/22 | MBRX | Moleculin Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klemp Walter V | TX | DO | CEO,P | P | 26 | 1.15 | 0 | 23 | 7 | 365 | D | ||||||||||||||
11/18/22 20:34 | 11/16/22 | MBRX | Moleculin Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klemp Walter V | TX | DO | CEO,P | P.m | 108 | 0.9810 | 0 | 110 | 47 | 342 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |